BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 09/04/2025

FDA Clears NASCOBAL Nasal Spray for Continued Sale

The FDA has determined that NASCOBAL cyanocobalamin nasal spray, 0.5 mg/spray, was not withdrawn from sale due to safety or effectiveness concerns, allowing it to continue being approved for use in abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →